Recombinant CCR2 (Plozalizumab Biosimilar) antibody (PE)

Catalog No. ABIN7867129

The PE-conjugated Humanized Monoclonal anti-CCR2 (Plozalizumab Biosimilar) antibody (ABIN7867129) specifically detects CCR2 (Plozalizumab Biosimilar) in FACS. The antibody is reactive with Human samples.

Quick Overview for Recombinant CCR2 (Plozalizumab Biosimilar) antibody (PE) (ABIN7867129)

Target: CCR2 (Plozalizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This CCR2 (Plozalizumab Biosimilar) antibody is conjugated to PE

Application: Flow Cytometry (FACS)

Product Details anti-CCR2 (Plozalizumab Biosimilar) Antibody (PE)

Purpose: PE-conjugated Anti-CCR2(plozalizumab biosimilar) mAb

Isotype: IgG1

Application Details

Application Notes: Flow Cyt 1:100

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Liquid PBS with 0.05 %  Proclin300, 1 % BSA

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment:  Store at 2°C-8°C for 6 months

Expiry Date: 6 months

Target Details for CCR2 (Plozalizumab Biosimilar)

Target: CCR2 (Plozalizumab Biosimilar)

Alternative Name: plozalizumab biosimilar

Target Type: Biosimilar

Background:

Synonyms: CC-CKR-2,CCR2A,CCR2B,CD192,CKR2,CKR2A,CKR2B,CMKBR2,MCP-1-R,MLN-1202, MLN1202, anti-CCR2, hu1D9

Target Background: Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

UniProt: P41597